GB-Salisbury: Pharmaceutical In Vitro Protein binding and blood partitioning Study
Defence Science & Technology Laboratory (DSTL) · £10,000 – £113,000 · closes 28 Feb 2018
£10,000 – £113,000
Estimated value
Closed
Deadline
13 Feb 2018
Published
This tender has closed.
See what's open in medical equipment and pharmaceuticals, or get contracts like this in your inbox each morning — free.
About this contract
The project is developing a medicinal product. As such it is planned to administer the two active pharmaceutical ingredients (APIs) of interest to humans in clinical trials. To maximise the understanding of how these APIs behave when administered to humans it is important to gain knowledge of their binding to plasma proteins and blood components. The results from these assays will be used to improve the understanding of the pharmacokinetics of these drugs as the project progresses. This requirement is for the in vitro assessment of plasma protein binding and whole blood to plasma ratio of the two APIs being developed in this project separately and in combination. Additional information: To view this notice, register as a supplier here: http://www.contracts.mod.uk/delta/signup.html?userType=supplier and search for the notice with reference 'GB-Salisbury: Pharmaceutical In Vitro Protein binding and blood partitioning Study'.
Key dates
Source
Who to contact
Tender documents
Similar open tenders
Contains public sector information licensed under OGL v3.0